Status:

COMPLETED

A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

HIV

Pregnancy Malaria

Eligibility:

FEMALE

16-55 years

Phase:

PHASE2

Brief Summary

More than 3 billion people worldwide are at risk of acquiring malaria and pregnant women living with HIV in Africa are at particular risk. An effective prophylaxis regimen capable of preventing malari...

Detailed Description

The World Health Organization (WHO) recommends malaria prophylaxis for all pregnant women living in endemic areas in order to reduce maternal anemia, low birth weight and perinatal mortality by 25-45%...

Eligibility Criteria

Inclusion

  • Confirmed HIV-infection (documented in medical record)
  • Age ≥16 years
  • Confirmed pregnancy, \<28 weeks estimated gestational age (by best obstetric estimate which may include ultrasound or fundal height and LMP)
  • Live singleton pregnancy
  • Receiving prenatal care at Mboppi Hospital or Mutengene Hospital
  • Plan to receive follow up prenatal care and deliver at study facility
  • Capable of providing written informed consent
  • Able and agree to come to facility for febrile episodes or acute illness during pregnancy (with reimbursement of transportation costs).
  • Agree to avoid antimalarial medications outside of study protocol.

Exclusion

  • Severe anemia (last hemoglobin \<6)
  • History of severe adverse reaction to co-trimoxazole or azithromycin
  • Active medical problem requiring inpatient evaluation at the time of screening
  • Intention of moving far away from the facility during pregnancy or not likely to return for follow up care or delivery
  • Signs or symptoms of early or active labor
  • History of severe cardiac disease (including congestive heart failure, severe valvular disease or arrhythmias).

Key Trial Info

Start Date :

March 7 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2022

Estimated Enrollment :

308 Patients enrolled

Trial Details

Trial ID

NCT03431168

Start Date

March 7 2018

End Date

January 1 2022

Last Update

November 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294